Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

AIM WINNERS & LOSERS: Revolution Beauty eyes fundraise as profit down

13th May 2025 11:02

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.

----------

AIM - WINNERS

----------

Eden Research PLC, up 14% at 3.13 pence, 12-month range 2.23p-5.00p. The developer of biopesticides and formulation technologies for the crop protection, animal health and consumer products industries receives approval in California for its flagship fungicide Mevalone for the control of powdery mildew in grapes. Sipcam Agro USA, which already acts as Eden's exclusive distributor for Mevalone in the US, will now actively promote Mevalone for this new use, as this is further to the approval already received for Mevalone in California for the control of Botrytis cinerea. While Eden believes the new approval increases its chance of achieving a greater market share among botryticides, it does not expect to change its revenue expectations in the near term. Eden estimates the total addressable market for Mevalone in the US at around EUR94 million, with California - as the country's largest grape producer - representing the largest share of this potential "by a substantial margin".

----------

AIM - LOSERS

----------

Revolution Beauty Group PLC, down 39% at 4.55p, 12-month range 3.86p-28.00p. The cosmetics retailer expects to report GBP141.6 million in revenue for its financial year that ended February 28, down 26% as a result of product and brand portfolio rationalisation. Underlying adjusted earnings before interest, tax, depreciation and amortisation is anticipated between GBP6.0 million and GBP6.5 million, against GBP12.6 million in adjusted Ebitda the year before. Revolution says trading in March and April has been "softer than planned" due to weakness in pure-play digital retailers, as well as weakened consumer confidence in the US. It expects these factors to only impact performance in the short to medium term, however. Cost and inventory management is expected to "significantly" mitigate the impact of lower sales on Ebitda in financial 2026. Revolution says it has confidence in its medium-term prospects, but notes that it would benefit from a more robust capital structure and is reviewing its funding structure as a result.

----------

Itim Group PLC, down 21% at 44.00p, 12-month range 28.00p-66.00p. The retail software solutions provider swings to a pretax profit of GBP175,000 in 2024 from a pretax loss of GBP1.1 million in 2023, driven by an 11% increase in Itim's top line to GBP17.9 million from GBP16.1 million. This is primarily attributed to a 34% increase in project revenue. Administrative expenses rise 8.3% to GBP4.7 million from GBP4.4 million, but with Itim noting that as a percentage of sales, it was down to 26% from 27% the prior year. In line with 2023, Itim proposed no dividend for 2024. Chief Executive Ali Athar described 2024 as "the most pivotal year for Itim since our IPO", as the business returned to profitability. Itim expresses confidence in the future but said it remains "mindful of the broader market backdrop and potential challenges". "We continue to invest in innovation and product excellence, underpinned by our unified retailing platform, 'Unify.' The strides we've made this year are a direct reflection of the commitment and talent of our team, as well as the continued trust placed in us by our customers," CEO Athar says. "As we look ahead, the board remains cautiously optimistic that our focus on margin enhancement and efficiency will support continued momentum and long-term value creation."

----------

By Emily Parsons, Alliance News reporter

Comments and questions to [email protected]

Copyright 2025 Alliance News Ltd. All Rights Reserved.


Related Shares:

EdenRevolution BeautyItim Grou
FTSE 100 Latest
Value8,556.04
Change-28.97